Brain tumor biopsies that are routinely performed in clinical settings significantly aid in diagnosis and staging. The aim of this study is to develop and evaluate a methodological image-guided approach that would allow for routine sampling of glioma tissue from orthotopic mouse brain tumor models. A magnetic resonance imaging-guided biopsy method is presented to allow for spatially precise stereotaxic sampling of a murine glioma coupled with genome-scale technology to provide unbiased characterization of intra- and intertumoral clonal heterogeneity. Longitudinal and multiregional sampling of intracranial tumors allows for successful collection of tumor biopsy samples, thus allowing for a pathway-enrichment analysis and a transcriptional pr...
The Cancer Genome Atlas Network recently catalogued recurrent genomic abnormalities in glioblastoma ...
Glioblastoma multiforme (GBM) is the most aggressive form of brain tumour with 5-year survival rates...
BACKGROUND: Genetic profiling represents the future of neuro-oncology but suffers from inadequate bi...
Background. Glioblastoma (GBM) exhibits profound intratumoral genetic heterogeneity. Each tumor comp...
Glioblastoma (GB) is a highly invasive primary brain tumor that almost systematically recurs despite...
Tumor heterogeneity presents a significant barrier to glioblastoma treatment. While multiparametric ...
International audienceGlioblastoma (GB) is a highly invasive primary brain tumor that almost systema...
Glioblastoma (GB) is the most common and aggressive primary brain malignancy, with poor prognosis an...
Glioblastoma (GBM) is the most invasive and deadliest brain cancer in adults. Its inherent heterogen...
The Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in glioblastoma m...
We propose a statistical multiscale mapping approach to identify microscopic and molecular heterogen...
Glioblastomas (GBMs) diffusely infiltrate the brain, making complete removal by surgical resection i...
SummaryThe Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in gliobla...
Glioblastomas (GBMs) are the most aggressive primary brain tumours and have no known cure. Each indi...
High-grade gliomas possess internal pathological heterogeneity. Selective sampling of different tumo...
The Cancer Genome Atlas Network recently catalogued recurrent genomic abnormalities in glioblastoma ...
Glioblastoma multiforme (GBM) is the most aggressive form of brain tumour with 5-year survival rates...
BACKGROUND: Genetic profiling represents the future of neuro-oncology but suffers from inadequate bi...
Background. Glioblastoma (GBM) exhibits profound intratumoral genetic heterogeneity. Each tumor comp...
Glioblastoma (GB) is a highly invasive primary brain tumor that almost systematically recurs despite...
Tumor heterogeneity presents a significant barrier to glioblastoma treatment. While multiparametric ...
International audienceGlioblastoma (GB) is a highly invasive primary brain tumor that almost systema...
Glioblastoma (GB) is the most common and aggressive primary brain malignancy, with poor prognosis an...
Glioblastoma (GBM) is the most invasive and deadliest brain cancer in adults. Its inherent heterogen...
The Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in glioblastoma m...
We propose a statistical multiscale mapping approach to identify microscopic and molecular heterogen...
Glioblastomas (GBMs) diffusely infiltrate the brain, making complete removal by surgical resection i...
SummaryThe Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in gliobla...
Glioblastomas (GBMs) are the most aggressive primary brain tumours and have no known cure. Each indi...
High-grade gliomas possess internal pathological heterogeneity. Selective sampling of different tumo...
The Cancer Genome Atlas Network recently catalogued recurrent genomic abnormalities in glioblastoma ...
Glioblastoma multiforme (GBM) is the most aggressive form of brain tumour with 5-year survival rates...
BACKGROUND: Genetic profiling represents the future of neuro-oncology but suffers from inadequate bi...